RIL
MBX

Rothschild Investment LLC’s MBX Biosciences MBX Stock Holding History

Rothschild Investment LLC’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$716 Hold
24
– – ﹤0.01% 3001
2025
Q4 		$757 Buy
24
+4
+20% +$97 ﹤0.01% 2773
2025
Q3 		$350 Hold
20
– – ﹤0.01% 2909
2025
Q2 		$228 Buy
+20
New +$204 ﹤0.01% 2915

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Rothschild Investment LLC's MBX Position: Q1 2026 in Review

Rothschild Investment LLC held its MBX Biosciences (MBX) position steady in Q1 2026 at 24 shares worth $716. The position accounts for ﹤0.01% of the portfolio, ranked #3001.

Rothschild Investment LLC first reported a position in MBX in Q2 2025 and has held it in 4 quarters since. The position peaked at $757 in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Rothschild Investment LLC held 24 shares of MBX Biosciences worth $716 as of Q1 2026.
  • Rothschild Investment LLC left its MBX Biosciences share count unchanged in Q1 2026.
  • MBX Biosciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #3001 holding.
  • Rothschild Investment LLC first reported a position in MBX Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Rothschild Investment LLC's MBX Biosciences position peaked at $757 in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.